Costs, effectiveness, and safety associated with chimeric antigen receptor (car) t-cell therapy: results from a comprehensive cancer center

HIGHLIGHTS

• who: Su00e9rgio Chacim and colleagues from the Editor:, Keio University School of have published the research work: Costs, effectiveness, and safety associated with Chimeric Antigen Receptor (CAR) T-cell therapy: Results from a comprehensive cancer center, in the Journal: PLOS ONE of 28/06/2022
• what: The authors aimed at describing CAR T-cells effectiveness safety and costs in a Portuguese Comprehensive Cancer Center.
• future: Prospective data will consolidate these results adding quality of life evaluation and Markov model analysis.

SUMMARY

Chimeric antigen receptor (CAR)-T_cells represent a new . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.